EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Laser Treatment of Central Serous Chorioretinopathy – An Update

Maciej Gawecki, Wiktoria Pytrus, Anna Swiech, Jerzy Mackiewicz, Lyubomyr Lytvynchuk

Klinische Monatsblätter für Augenheilkunde · 2024-11 · 241 (11) · 1207-1223

DOI: 10.1055/a-2338-3235 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, online erschienen am 24.07.2024. Verfasst von Maciej Gawecki und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Dobry Wzrok Ophthalmological Clinic, Gdansk, Poland. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Laser Coagulation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 146 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Laser treatment has been a mainstay for management of central serous chorioretinopathy for a few decades. Different types of lasers have been used and non-damaging retinal laser is the most recent option. The aim of this review is to provide an update on this form of treatment, based on the research published during last 5 years, in comparison with earlier studies published. A MEDLINE database search was performed with a combination of the following terms: central serous chorioretinopathy and laser photocoagulation or subthreshold laser or subthreshold micropulse laser or nanosecond laser or microsecond laser or end-point management or photodynamic therapy. Results were analyzed separately for each modality of laser treatment. Reports published in recent years confirm findings of previous research and do not distinguish treatments of this clinical entity. Among all analyzed laser options, photodynamic therapy provides the fastest and most prominent morphological improvements, including subretinal fluid resorption and reduction of choroidal thickness. This modality is also associated with fewer recurrences than with other treatments. Subthreshold micropulse laser allows the physician to maintain and, in selected cases, improve the patientʼs vision. Conventional photocoagulation is still effective, especially with the introduction of navigated laser systems. Despite the availability of variable laser treatment options, long-term functional improvements in chronic cases are minor for each modality. Long-lasting central serous chorioretinopathy cases with significantly altered retinal morphology do not usually present with functional improvement, despite satisfactory morphological outcomes. Early initiation of treatment has the potential to prevent visual loss and to improve the patientʼs quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyLaser CoagulationHumansTreatment OutcomePhotochemotherapyEvidence-Based Medicine

Autor:innen und Institutionen

  • Ophthalmology, Dobry Wzrok Ophthalmological Clinic, Gdansk, Poland.
  • Ophthalmology, University Hospital Wroclaw, Poland.
  • Chair of Ophthalmology, Department of Vitreoretinal Surgery, Medical University of Lublin, Poland.
  • Department of Ophthalmology, Eye Clinic, Justus Liebig University, University Hospital Giessen and Marburg, Campus Giessen, Giessen, Germany.

Zitieren

APA

Gawecki, M., Pytrus, W., Swiech, A., Mackiewicz, J., & Lytvynchuk, L. (2024). Laser Treatment of Central Serous Chorioretinopathy – An Update. Klinische Monatsblätter für Augenheilkunde, 241(11), 1207-1223. https://doi.org/10.1055/a-2338-3235

Vancouver

Gawecki M, Pytrus W, Swiech A, Mackiewicz J, Lytvynchuk L. Laser Treatment of Central Serous Chorioretinopathy – An Update. Klinische Monatsblätter für Augenheilkunde. 2024;241(11):1207-1223. doi:10.1055/a-2338-3235

BibTeX
@article{Gawecki2024,
  author = {Gawecki, Maciej and Pytrus, Wiktoria and Swiech, Anna and Mackiewicz, Jerzy and Lytvynchuk, Lyubomyr},
  title = {Laser Treatment of Central Serous Chorioretinopathy – An Update},
  journal = {Klinische Monatsblätter für Augenheilkunde},
  year = {2024},
  volume = {241},
  number = {11},
  pages = {1207--1223},
  doi = {10.1055/a-2338-3235}
}
Kostenlos starten →